• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

probiotics

Pharma & Human Health

New Guide From American Gastroenterological Association for Probiotics Consumers

June 20, 2018 Microbiome Times

The use of probiotics has skyrocketed in recent years, with more than 3.9 million American adults taking probiotics.1 At the same time, there is limited scientific data supporting the health claims of probiotics, as well […]

Animal Health

Microbial LLC Launches Profauna 100, a High-Count, Multi-Strain Probiotic for Dogs to Support Digestive Health

June 8, 2018 Microbiome Times

The Microbial LLC, a company primarily focused on developing and commercializing high quality pet probiotics that benefit the animal microbiome, launched Profauna 100, a new high-count, multi-strain probiotic specifically developed to support a dog’s digestive […]

Pharma & Human Health

New AZO Product Restores and Protects Vaginal Health

May 17, 2018 Microbiome Times

Most women will experience the discomfort that accompanies vaginal imbalance at some point in their lives. Everyday activities and stressors, from sex to tight clothing or even diet and medication, can all disrupt vaginal health. […]

Finance

Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing

May 16, 2018 Microbiome Times

Thryve, providers of high quality microbiotics and microbiome testing, announced today it has secured $1.4 million in funding. Participating investment firms include PivotNorth Capital, Unilever Ventures, Darling Ventures, Candela Paramount, Abstract Ventures and Joyance Partners. […]

Pharma & Human Health

Chr. Hansen reaches major milestone in innovation pipeline

May 16, 2018 Microbiome Times

Chr. Hansen completed a clinical trial1 using a carefully selected probiotic strain. Reaching both the primary and secondary end points of the trial, the results show a robust protective effect against gastrointestinal (GI) side effects […]

Pharma & Human Health

DuPont Files Patent For the Use of Bacteria, Metabolites and Compositions for Blood Type Specific Probiotics

May 9, 2018 Microbiome Times

Here is the summary of the patent submitted: The present invention is based on the inventors’ surprising discovery that certain bacterial strains showed enhanced in vitro adhesion to one or more of the ABO biood […]

Finance

UAS Laboratories Expands Capabilities With New Fermentation Facility

May 6, 2018 Microbiome Times

UAS Laboratories LLC (Wausau, Wisconsin, USA), is celebrating a significant milestone with the opening of their new fermentation facility, located in Madison, Wisconsin, USA. This expansion is the result of a 60-million-dollar investment made to […]

Pharma & Human Health

Prota Therapeutics Partners With World Leading Bioscience Company, Chr. Hansen

April 20, 2018 Microbiome Times

Allergy immunotherapy company Prota Therapeutics Pty Ltd (Prota), is pleased to announce it has partnered with Chr. Hansen, a leading global bioscience company, to manufacture and supply pharmaceutical quality LGG®1 probiotic strain, Lactobacillus rhamnosus, initially […]

Pharma & Human Health

Optibiotix Health plc Signs 5 year Exclusive Agreement with Trigen Pharma

April 18, 2018 Microbiome Times

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it has entered into a five year distribution agreement with Trigen Pharma International (Pvt) […]

Finance

Synlogic Announces Registered Direct Offering of Common Stock

April 6, 2018 Microbiome Times

Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced that it has agreed to sell 3,280,000 shares of its common stock to a large mutual […]

Pharma & Human Health

Morinaga Milk’s New Probiotic Strain, Bifidobacterium breve A1, May Prevent Onset of Alzheimer’s Disease

March 20, 2018 Microbiome Times

Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced the results of a new study investigating the preventive effects of its new probiotic strain Bifidobacterium breve A1 on a model […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
  • DNA Genotek enables development of microbiome-based clinical applications with OMNIgene™•GUT Dx – the first and only FDA-authorized fecal self-collection device
    May 10, 2023
  • Seres Therapeutics and Nestlé Health Science Announce FDA Approval of VOWST™
    April 27, 2023
  • Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
    April 25, 2023
  • Researchers create virus-resistant, safely restrained E. coli
    April 10, 2023
sign up

Sign up to the Microbiome Times newsletter